Published in Am J Pathol on May 01, 1999
Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer. World J Gastroenterol (2003) 1.11
Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound. Cancer Res (2010) 0.97
Compound K, a metabolite of ginseng saponin, induces mitochondria-dependent and caspase-dependent apoptosis via the generation of reactive oxygen species in human colon cancer cells. Int J Mol Sci (2010) 0.91
Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogs. Invest New Drugs (2010) 0.88
Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells. Blood (2014) 0.86
Differential effects of procaspase-3 activating compounds in the induction of cancer cell death. Mol Pharm (2012) 0.84
Anticancer effects of oligomeric proanthocyanidins on human colorectal cancer cell line, SNU-C4. World J Gastroenterol (2005) 0.78
Targeting procaspase-3 with WF-208, a novel PAC-1 derivative, causes selective cancer cell apoptosis. J Cell Mol Med (2015) 0.77
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood (1994) 21.00
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (1995) 15.07
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (1988) 14.66
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell (1991) 10.96
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell (1993) 10.35
The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell (1994) 9.25
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell (1995) 9.22
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell (1993) 9.06
A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med (1998) 8.24
Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (1989) 7.76
Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell (1994) 7.23
Human ICE/CED-3 protease nomenclature. Cell (1996) 7.11
A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med (1989) 7.07
Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci U S A (1986) 5.54
Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (1996) 4.92
Fas and Fas ligand: lpr and gld mutations. Immunol Today (1995) 4.69
C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell (1994) 4.66
Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science (1995) 4.41
Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (1995) 4.20
Substrate specificities of caspase family proteases. J Biol Chem (1997) 4.16
Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem (1996) 3.97
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (1995) 3.59
Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem (1992) 3.48
Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med (1994) 3.11
Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol (1994) 2.74
CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem (1996) 2.40
Fas-induced activation of the cell death-related protease CPP32 Is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem (1996) 2.26
Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci U S A (1998) 2.04
Cell-specific induction of apoptosis by microinjection of cytochrome c. Bcl-xL has activity independent of cytochrome c release. J Biol Chem (1997) 1.97
Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities. Genes Dev (1996) 1.77
Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J Immunol (1995) 1.50
Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood (1998) 1.41
Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene (1996) 1.40
Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Blood (1996) 1.24
Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. Am J Pathol (1988) 1.21
Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes. Blood (1997) 1.18
Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J Biol Chem (1998) 1.13
Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood (1997) 1.08
ERICE, a novel FLICE-activatable caspase. J Biol Chem (1998) 1.06
In vitro and in vivo studies of ICE inhibitors. J Cell Biochem (1997) 1.00
Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res (1996) 0.98
Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity. J Immunol (1996) 0.92
Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. Am J Pathol (1996) 0.89
An interleukin-1beta converting enzyme-like protease is a key component of Fas-mediated apoptosis. J Biol Chem (1996) 0.88
Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease. Blood (1996) 0.88
Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol (1997) 0.87
Lymphocyte predominance Hodgkin's disease (nodular paragranuloma)--a bcl-2 negative germinal centre lymphoma. Histopathology (1991) 0.84
Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis. Leukemia (1997) 0.83
Immunohistochemical analysis of interleukin-1beta-converting enzyme/Ced-3 family protease, CPP32/Yama/Caspase-3, in Hodgkin's disease. Blood (1997) 0.83
High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood (1995) 0.81
Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease. Mod Pathol (1995) 0.81
Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma. Am J Surg Pathol (1991) 0.80
Cysteine protease CPP32, but not Ich1-L, is expressed in germinal center B cells and their neoplastic counterparts. Hum Pathol (1997) 0.80
Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma. Ann Oncol (1996) 0.79
Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines. Br J Haematol (1997) 0.78
Proteases in Fas-mediated apoptosis. J Cell Biochem (1997) 0.78
bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus. Am J Clin Pathol (1993) 0.77
Bcl-x gene expression in Hodgkin's disease. Leuk Lymphoma (1996) 0.76
The t(14;18) chromosomal translocation and Bcl-2 protein expression in Hodgkin's disease. Leukemia (1994) 0.76
Expression of Fas and apoptosis of a Hodgkin's disease cell line (HD-70) Int J Hematol (1997) 0.76
Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med (1993) 2.17
Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet (1996) 1.91
Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol (1999) 1.89
The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma. Am J Clin Pathol (2001) 1.84
Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS (1997) 1.65
Alteration of monocyte function following major injury. Arch Surg (1988) 1.64
Intrathymic signalling in immature CD4+CD8+ thymocytes results in tyrosine phosphorylation of the T-cell receptor zeta chain. Nature (1989) 1.62
Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. Am J Surg Pathol (2000) 1.59
Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol (1999) 1.57
Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood (2001) 1.54
Classification of primary gastric lymphomas according to histologic features. Am J Surg Pathol (1998) 1.49
Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases. Am J Clin Pathol (2001) 1.46
UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation. Leukemia (2008) 1.39
Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ (2002) 1.35
Extramedullary plasmacytoma. A form of marginal zone cell lymphoma? Am J Clin Pathol (1999) 1.31
Pitting function of the spleen in malaria: ultrastructural observations. Science (1972) 1.28
Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis. Br J Haematol (2001) 1.22
Comparison of methods for extracting DNA from formalin-fixed paraffin sections for nonisotopic PCR. Diagn Mol Pathol (1996) 1.20
Histone deacetylase inhibitors induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t(15;17). Br J Haematol (2001) 1.12
Protein kinase Cdelta is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J Biol Chem (1998) 1.10
CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood (1990) 1.10
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma. Clin Cancer Res (1999) 1.09
Acinar pancreatic tumor with metastatic fat necrosis: report of a case and review of rheumatic manifestations. Am J Dig Dis (1976) 1.08
Precursor B-lymphoblastic transformation of grade I follicle center lymphoma. Am J Clin Pathol (2000) 1.07
Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm. Hum Pathol (1997) 1.07
Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol (2001) 1.06
Apoptosis in keratinocytes is not dependent on induction of differentiation. Lab Invest (1997) 1.04
Precursor B lymphoblastic lymphoma presenting as lytic bone lesions. Am J Clin Pathol (1999) 1.04
Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma. Br J Haematol (2004) 1.04
Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N Engl J Med (1995) 1.04
Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma. Leuk Lymphoma (2006) 1.03
Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis. Hum Pathol (2000) 1.03
Leukemic phase of reticulum cell sarcoma (histiocytic lymphoma). A clinicopathologic and ultrastructural study. Cancer (1973) 1.02
Application of flow cytometry to diagnostic pathology. Lab Invest (1984) 1.02
In situ polymerase chain reaction-based localization studies support role of human herpesvirus-8 as the cause of two AIDS-related neoplasms: Kaposi's sarcoma and body cavity lymphoma. J Clin Invest (1997) 1.00
Detection of immunoglobulin heavy chain gene rearrangement by polymerase chain reaction in chronic active gastritis associated with Helicobacter pylori. Hum Pathol (1996) 0.98
Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am J Pathol (1997) 0.98
Follicular lymphoma with marginal zone differentiation: microdissection demonstrates the t(14;18) in both the follicular and marginal zone components. Mod Pathol (2001) 0.98
Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis. Br J Haematol (1993) 0.96
Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets. J Infect Dis (1986) 0.96
Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma. Chest (1999) 0.96
Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease. Arch Pathol Lab Med (1986) 0.96
Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells. Mod Pathol (2001) 0.96
Kaposi's sarcoma tumor cells preferentially express Bcl-xL. Am J Pathol (1996) 0.96
ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas. Leukemia (2005) 0.94
Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features. J Clin Oncol (2002) 0.94
Erythrocytes: pits and vacuoles as seen with transmission and scanning electron microscopy. Science (1971) 0.94
Dual role for Afipia felis and Rochalimaea henselae in cat-scratch disease. Lancet (1995) 0.94
Ectopic prostatic tissue in urethra: a clinocopathological entity and a significant cause of hematuria. J Urol (1971) 0.93
Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res (1999) 0.93
Hairy-cell leukemia. A clinicopathologic and ultrastructural study. Am J Clin Pathol (1974) 0.92
Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes. Diagn Mol Pathol (2001) 0.92
T-cell receptor gene rearrangement in regressing atypical histiocytosis. Arch Dermatol (1987) 0.92
Geographically distinct HHV-8 DNA sequences in Saudi Arabian Iatrogenic Kaposi's sarcoma lesions. Am J Pathol (1998) 0.92
Rearrangement of immunoglobulin and T-cell receptor genes in Hodgkin's disease. Am J Pathol (1988) 0.91
Guidelines for HER2 testing in the UK. J Clin Pathol (2004) 0.91
Regressing atypical histiocytosis: a review and critical appraisal. Semin Diagn Pathol (1987) 0.91
Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. A clinicopathologic study. Cancer (1969) 0.90
Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin Exp Immunol (1989) 0.90
Detection of Philadelphia chromosome-positive cells from glass slide smears using the polymerase chain reaction. Am J Pathol (1990) 0.90
Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism. Ann Oncol (2010) 0.90
CD30 (Ki-1)-positive, anaplastic large cell lymphoma mimicking gastrointestinal carcinoma. Cancer (1992) 0.89
Primary T-cell lymphoma of the adrenal glands with adrenal insufficiency. Hum Pathol (1986) 0.89
Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients. Am J Surg Pathol (2000) 0.89
Extranodal head and neck lymphomas: result of radiation therapy. Int J Radiat Oncol Biol Phys (1979) 0.89
Superantigens, autoantigens, and pathogenic T cells in psoriasis. J Invest Dermatol (1998) 0.89
Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen. Bone Marrow Transplant (2007) 0.88
Chicken growth-associated protein (GAP)-43: primary structure and regulated expression of mRNA during embryogenesis. Brain Res Mol Brain Res (1990) 0.88
Desquamative interstitial pneumonia. Case report of an infant unresponsive to treatment. Am J Dis Child (1973) 0.88
Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells. Mod Pathol (2000) 0.88
Esophageal involvement in lymphoma. Am J Gastroenterol (1985) 0.87
Lymphoproliferative disorders in chronic hepatitis C. J Viral Hepat (2004) 0.87
Molecular and pathologic characterization of an AIDS-related body cavity-based lymphoma, including ultrastructural demonstration of human herpesvirus-8: a case report. Am J Surg Pathol (1998) 0.87
T-and B-cell lymphomas look alike. Am J Clin Pathol (1980) 0.87
Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping. Hum Pathol (1992) 0.86
Lymphosarcoma cell leukemia. A clinicopathological study. Cancer (1970) 0.86
The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders. J Cutan Pathol (1997) 0.86
An ultrastructural study of the red pulp of the spleen in malaria. Blood (1973) 0.86
Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2. J Immunol (1989) 0.86
Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest (1998) 0.86
Increased numbers of lymphocytes with single class surface immunoglobulins in reactive hyperplasia of lymphoid tissue. Am J Clin Pathol (1982) 0.86
Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. Leukemia (2005) 0.85
Gamma/delta T-cell posttransplantation lymphoproliferative disorder primarily in the spleen. Am J Clin Pathol (1994) 0.85
A modified surgical technique for repairing third-degree perineal lacerations in mares. Acta Vet Hung (2005) 0.84
Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions. J Dermatol Sci (1999) 0.84
Splenomegaly without an apparent cause. Surg Gynecol Obstet (1982) 0.84
Complement receptor B lymphocytes in nodular sclerosing Hodgkin's disease. Cancer (1977) 0.83
Spleen and lymph node cell populations, in vitro cell proliferation and interferon-gamma production during the primary immune response to Toxoplasma gondii. Parasite Immunol (1986) 0.83
Post-transplantation lymphoproliferative disorder of the NK-cell type: a case report and review of the literature. Mod Pathol (1998) 0.83
A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma. Histopathology (2000) 0.83
Is there a role for folate determinations in current clinical practice in the USA? Clin Lab Haematol (2004) 0.83
Observations of phagocytized red cells containing Heinz bodies. A light and electron microscopic study. Am J Clin Pathol (1966) 0.83
Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein. Exp Hematol (2001) 0.82